https://scholars.lib.ntu.edu.tw/handle/123456789/558193
標題: | Histologic Transformation in a Patient with Lung Cancer Treated with Chemotherapy and Pembrolizumab | 作者: | CHIA-LIN HSU KUAN-YU CHEN SHUENN-WEN KUO YIH-LEONG CHANG |
公開日期: | 2017 | 出版社: | Elsevier Inc | 卷: | 12 | 期: | 6 | 起(迄)頁: | e75-e76 | 來源出版物: | Journal of Thoracic Oncology | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019373716&doi=10.1016%2fj.jtho.2017.02.006&partnerID=40&md5=f23756a236de18ab66633fd55777bfc4 https://scholars.lib.ntu.edu.tw/handle/123456789/558193 |
ISSN: | 1556-0864 | DOI: | 10.1016/j.jtho.2017.02.006 | SDG/關鍵字: | anaplastic lymphoma kinase; cytokeratin 7; docetaxel; epidermal growth factor receptor; pembrolizumab; pemetrexed; programmed death 1 ligand 1; protein p40; thyroid transcription factor 1; vimentin; vinorelbine tartrate; immunological antineoplastic agent; monoclonal antibody; pembrolizumab; aged; ALK gene; cancer chemotherapy; cancer growth; cancer radiotherapy; case report; computer assisted tomography; drug efficacy; drug safety; dyspnea; EGFR gene; follow up; gene mutation; gene translocation; human; human tissue; Letter; lung biopsy; lymphadenopathy; male; mediastinum lymphadenopathy; multiple cycle treatment; non small cell lung cancer; pleura effusion; priority journal; protein expression; supraclavicular lymphadenopathy; treatment response; adenocarcinoma; chemically induced; lung tumor; non small cell lung cancer; pathology; prognosis; squamous cell carcinoma; Adenocarcinoma; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Humans; Lung Neoplasms; Male; Prognosis |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。